Clinical trials
Completed Coronavirus Infections trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 7 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bharat Biotech International Limited | 1 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| Kirby Institute | 1 |
| Level 42 AI, Inc. | 1 |
| MGC Pharmaceuticals d.o.o | 1 |
| PUNEET MITTAL | 1 |
| Population Health Research Institute | 1 |
| The Herb, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronavirus Infections | 9 |
| COVID-19 | 8 |
| Severe Acute Respiratory Syndrome | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Thrombosis | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.